Markets

Market Nav

News Details

05/02/2026 16:30

Marksans Pharma Q3 net profit up 9.83% at Rs 60.91 cr

The company reported standalone net profit of Rs 60.91 crore for the quarter ended December 31, 2025 as compared to Rs 55.46 crore in the same period last year, registering a year-on-year growth of 9.83 per cent.

Net revenue of the company rose moderately by 8.93 per cent at Rs 339.73 crore in October-December quarter of this fiscal as against Rs 311.87 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 4.90 per cent to Rs 264.28 crore from Rs 251.93 crore in year ago period.

Other Income dipped by 29.54 per cent at Rs 15.86 crore versus (Dec'24 Rs 22.51 crore).

Operating Profit surged by 25.88 per cent to Rs 75.45 crore as against Rs 59.94 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 15.56 per cent in December quarter.

Interest grew by 20.00 per cent y-o-y to Rs 0.36 crore, while Taxation increased by 10.07 per cent at Rs 21.20 crore (Dec'24 Rs 19.26 crore).